We are live on
!
Find out more
DWA
Delos Wealth Advisors Portfolio holdings
AUM
$195M
1-Year Est. Return
23.25%
This Fund
S&P 500
This Quarter
Est. Return
+6.89%
1 Year Est. Return
+23.25%
3 Year Est. Return
+58.01%
5 Year Est. Return
+65.3%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$14.1M
(+15%)
Cap. Flow
+$8.73M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
48.05%
Holding
494
New
251
Increased
96
Reduced
10
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$1.5M |
| 2 |
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
|
+$463K |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$283K |
| 4 |
SPDR Gold Trust
GLD
|
+$207K |
| 5 |
Microsoft
MSFT
|
+$194K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$89K |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$44K |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.1K |
| 4 |
CMA
Comerica
CMA
|
+$20K |
| 5 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$10.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.47% |
| 2 | Industrials | 5.74% |
| 3 | Technology | 5.21% |
| 4 | Materials | 4.88% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Encompass Health
EHC
$12B
| $5K | ﹤0.01% |
+91
| New | +$4.7K |
|
302
Evercore
EVR
$10.4B
| $5K | ﹤0.01% |
+38
| New | +$5.54K |
|
303
HDFC Bank
HDB
$116B
| $5K | ﹤0.01% |
+166
| New | +$5.81K |
|
304
Hamilton Lane
HLNE
$5.13B
| $5K | ﹤0.01% |
+51
| New | +$5.24K |
|
305
Home BancShares
HOMB
$6.04B
| $5K | ﹤0.01% |
+214
| New | +$5.27K |
|
306
Interparfums
IPAR
$3.52B
| $5K | ﹤0.01% |
+46
| New | +$4.13K |
|
307
KB Home
KBH
$3.04B
| $5K | ﹤0.01% |
+113
| New | +$4.73K |
|
308
Littelfuse
LFUS
$10B
| $5K | ﹤0.01% |
+17
| New | +$5.14K |
|
309
LKQ Corp
LKQ
$5.92B
| $5K | ﹤0.01% |
+88
| New | +$4.97K |
|
310
LeMaitre Vascular
LMAT
$1.84B
| $5K | ﹤0.01% |
+107
| New | +$5.53K |
|
311
Landstar System
LSTR
$5.86B
| $5K | ﹤0.01% |
+28
| New | +$4.8K |
|
312
MGP Ingredients
MGPI
$308M
| $5K | ﹤0.01% |
+60
| New | +$4.52K |
|
313
Monro
MNRO
$391M
| $5K | ﹤0.01% |
+80
| New | +$4.73K |
|
314
Materion
MTRN
$4.99B
| $5K | ﹤0.01% |
+57
| New | +$4.75K |
|
315
Northern Oil and Gas
NOG
$2.89B
| $5K | ﹤0.01% |
+261
| New | +$5.83K |
|
316
Phillips 66
PSX
$106B
| $5K | ﹤0.01% |
+66
| New | +$4.99K |
|
317
Sonoco
SON
$4.77B
| $5K | ﹤0.01% |
+86
| New | +$5.14K |
|
318
Shutterstock
SSTK
$180M
| $5K | ﹤0.01% |
+43
| New | +$5K |
|
319
Universal Health Services
UHS
$10.4B
| $5K | ﹤0.01% |
+39
| New | +$5.01K |
|
|
WCN
320
Waste Connections
WCN
$40.1B
| $5K | ﹤0.01% |
+36
| New | +$4.79K |
|
|
Y
321
DELISTED
Alleghany Corp
Y
| $5K | ﹤0.01% |
+7
| New | +$4.66K |
|
322
ABM Industries
ABM
$2.93B
| $4K | ﹤0.01% |
+88
| New | +$3.97K |
|
323
Allison Transmission
ALSN
$10.1B
| $4K | ﹤0.01% |
+117
| New | +$4.13K |
|
324
Algonquin Power & Utilities
AQN
$4.07B
| $4K | ﹤0.01% |
+277
| New | +$3.96K |
|
325
Alibaba
BABA
$272B
| $4K | ﹤0.01% |
+34
| New | +$4.95K |
|
Similar funds
SL
WM
TCOK
FI
MWM
SRA
CC
BAM
Delos Wealth Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Delos Wealth Advisors held 494 positions worth $105M, up 15% from $91M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Delos Wealth Advisors deployed $8.73M of net new capital in Q4 2021, opening 251 new positions and adding to 96 existing holdings. Its largest new stake was Eaton Vance National Municipal Opportunities Trust: 4,750 shares worth $105K.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 76% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $89K trimmed.
- Delos Wealth Advisors's largest Q4 2021 buy was Eaton Vance National Municipal Opportunities Trust: 4,750 shares worth $105K.
- Delos Wealth Advisors added most to Invesco S&P 500 Pure Value ETF in Q4 2021, an estimated $1.5M increase.
- Delos Wealth Advisors's biggest Q4 2021 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $89K.
- Delos Wealth Advisors fully exited Axonics, Inc. Common Stock in Q4 2021, selling an estimated $44K.
- Delos Wealth Advisors's ten largest holdings make up 48% of its $105M portfolio in Q4 2021.
- Delos Wealth Advisors opened 251 new positions and closed 43 in Q4 2021.
- Delos Wealth Advisors's portfolio value rose 15% quarter-over-quarter to $105M.
Based on Delos Wealth Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.